• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Zyprexa (olanzapine) May 2002

Audience: Pharmacists and Neuro-psychiatric healthcare professionals

Eli Lilly notified healthcare professionals of product tampering with Zyprexa, indicated for the treatment of schizophrenia and acute bipolar mania. In a small number of tampering incidents, pharmacists in the United States have found Zyprexa 10 and 15 mg bottles which have had all of the Zyprexa tablets removed and replaced with white tablets marked, "aspirin." The reports, thus far, have been confined to 60 count 10 mg and 15 mg bottles of Zyprexa. These incidents appear to be isolated and limited in scope and no injuries or adverse effects related to the tampering have been reported to date.

[May 4, 2002 - Letter: Dear Healthcare Professional - Eli Lilly]
[May 4, 2002 - Letter: Dear Pharmacist - Eli Lilly]